JPMorgan Maintains Regeneron at Overweight, Raises Price Target to $1,050
JPMorgan raised its price target from $950 to $1,050 while maintaining its Overweight rating.
Story updates
12:28:14 AM UTC
SquawkNews
Regeneron Pharma Price Target Raised to $1050.00/Share From $950.00 by JP Morgan